Methocarbamol
Product Images NDC 52959-099

3 FDA label images from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methocarbamol (NDC 52959-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Methocarbamol (Methocarbamol Tabs 500mg 750mg 1)

Structural Formula Of Methocarbamol (Methocarbamol Tabs 500mg 750mg 1)
Chemical structure of Methocarbamol showing its molecular arrangement with a benzene ring, methoxy groups, and other functional groups attached.*
FDA Label Image

Ndc 0591-5381-01methocarbamol Tablets Usp500 mg 100 Tablets Rx Only (Methocarbamol Tabs 500mg 750mg 2)

Ndc 0591-5381-01methocarbamol Tablets Usp500 mg 100 Tablets  Rx Only (Methocarbamol Tabs 500mg 750mg 2)
Methocarbamol 500 mg tablet prescription label from H.J. Harkins Company, Inc. The label includes lot number MET508WL, manufacturer Watson PHA India, expiration date 12/10, and comparison to Robaxin. The tablet description indicates a white round pill identified as Pill D. The label advises to take as directed by a doctor or see outsert for dosage information and includes multiple barcodes and repack information.*
FDA Label Image

Ndc 0591-5382-01methocarbamol Tablets Usp750 mg 100 Tablets Rx Only (Methocarbamol Tabs 500mg 750mg 3)

Ndc 0591-5382-01methocarbamol Tablets Usp750 mg 100 Tablets  Rx Only (Methocarbamol Tabs 500mg 750mg 3)
Packaging label for Methocarbamol 750 mg tablets by H.J. Harkins Company, Inc. The label includes a comparison to Robaxin, manufactured by Watson Lab in India. It specifies the lot number ME704WL, expiration 04/12, and describes the dosage form as a white capsule-shaped tablet. The label also contains a usage direction note instructing to take as directed by a doctor or see the outer package for dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.